Key result
CPAP therapy may improve endothelial function and reduce cardiovascular risk in obstructive sleep apnea.
Answers are grounded in this paper and cite their sources.
Obstructive sleep apnea (OSA) is known to be an independent cardiovascular risk factor. Among arousal from sleep, increased thoracic pressure and enhanced sympathetic activation, intermittent hypoxia is now considered as one of the most important pathophysiological mechanisms contributing to the development of endothelial dysfunction. Nevertheless, not much is known about blood components, which justifies the current review. This review focuses on molecular mechanisms triggered by sleep apnea. The recurrent periods of hypoxemia followed by reoxygenation promote reactive oxygen species (ROS) overproduction and increase inflammatory response. In this review paper we also intend to summarize the effect of treatment with continuous positive airway pressure (CPAP) on changes in the profile of the endothelial function and its subsequent potential clinical advantage in lowering cardiovascular risk in other comorbidities such as diabetes, atherosclerosis, hypertension, atrial fibrillation. Moreover, this paper is aimed at explaining how the presence of OSA may affect platelet function and exert effects on rheological activity of erythrocytes, which could also be the key to explaining an increased risk of stroke.
No takes yet. Share an insight, caveat, or question.
Mochol et al. (2021) conducted a review in Obstructive sleep apnea and associated cardiovascular disorders. Continuous positive airway pressure (CPAP) was evaluated. Obstructive sleep apnea promotes endothelial dysfunction, platelet activation, and erythrocyte changes via intermittent hypoxia, while CPAP therapy may improve endothelial function and lower CV risk.
Synapse has enriched 10 related papers. Consider them for comparative context: